Literature DB >> 15643650

Glycan side chains on naturally presented MHC class II ligands.

Jörn Dengjel1, Hans-Georg Rammensee, Stefan Stevanovic.   

Abstract

The molecular characterization of unknown naturally presented major histocompatibility complex (MHC) class II glycopeptides carrying complex glycans has so far not been achieved, reflecting the different fragmentation characteristics of sugars and peptides in mass spectrometric analysis. Human leukocyte antigen (HLA)-DR-bound peptides were isolated by affinity purification, separated via high performance liquid chromatography and analyzed by matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. We were able to identify two naturally processed MHC class II ligands, CD53(122-136) and CD53(121-136), carrying complex N-linked glycan side chains by a combination of in-source and collision-induced fragmentation on a quadrupole time-of-flight tandem mass spectrometer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643650     DOI: 10.1002/jms.780

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  11 in total

1.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.

Authors:  Jörn Dengjel; Oliver Schoor; Rainer Fischer; Michael Reich; Marianne Kraus; Margret Müller; Katharina Kreymborg; Florian Altenberend; Jens Brandenburg; Hubert Kalbacher; Roland Brock; Christoph Driessen; Hans-Georg Rammensee; Stefan Stevanovic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

Review 2.  Post-translationally modified T cell epitopes: immune recognition and immunotherapy.

Authors:  Jan Petersen; Anthony W Purcell; Jamie Rossjohn
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

3.  Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.

Authors:  Stacy A Malaker; Michael J Ferracane; Florence R Depontieu; Angela L Zarling; Jeffrey Shabanowitz; Dina L Bai; Suzanne L Topalian; Victor H Engelhard; Donald F Hunt
Journal:  J Proteome Res       Date:  2016-09-13       Impact factor: 4.466

4.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 5.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

6.  Recent Development in Carbohydrate Based Anti-cancer Vaccines.

Authors:  Zhaojun Yin; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2012-02-29       Impact factor: 1.667

7.  Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.

Authors:  Simani Gaseitsiwe; Davide Valentini; Raija Ahmed; Shahnaz Mahdavifar; Isabelle Magalhaes; Johannes Zerweck; Mike Schutkowski; Emmanuel Gautherot; Felix Montero; Anneka Ehrnst; Marie Reilly; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

8.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Porcine Reproductive and Respiratory Syndrome Virus Promotes SLA-DR-Mediated Antigen Presentation of Nonstructural Proteins To Evoke a Nonneutralizing Antibody Response In Vivo.

Authors:  Chunyan Wu; Bingjun Shi; Di Yang; Kun Zhang; Jie Li; Jie Wang; Hongliang Liu; Qin Zhao; En-Min Zhou; Yuchen Nan
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

10.  Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.

Authors:  Kasper Winther Jørgensen; Søren Buus; Morten Nielsen
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.